RIG SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Transocean Ltd. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! — Neutral
RIG Accesswire — February 11, 2025NEW YORK, NY / ACCESS Newswire / February 11, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Transocean Ltd. ("Transocean" or "the Company") (NYSE:RIG) and certain of its officers.

PCRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Pacira BioSciences, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! — Neutral
PCRX Accesswire — February 11, 2025NEW YORK CITY, NY / ACCESS Newswire / February 11, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Pacira BioSciences, Inc. ("Pacira" or "the Company") (NASDAQ:PCRX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Pacira securities between August 2, 2023 and August 8, 2024, both dates inclusive (the "Class Period").

APLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! — Neutral
APLT Accesswire — February 11, 2025NEW YORK, NY / ACCESS Newswire / February 11, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").

AZN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that AstraZeneca PLC Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! — Neutral
AZN Accesswire — February 11, 2025NEW YORK CITY, NY / ACCESS Newswire / February 11, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against AstraZeneca PLC ("AstraZeneca" or "the Company") (NASDAQ:AZN) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired AstraZeneca securities between February 23, 2022 and December 17, 2024, both dates inclusive (the "Class Period").

Voyager Provides Update on SOD1 ALS Gene Therapy Program — Neutral
VYGR GlobeNewsWire — February 11, 2025- Company to assess alternate payloads; no changes planned to novel capsid component - - Resulting shift of timeline and costs extends cash runway into mid-2027 – - All other programs remain on track; IND filings expected in 2025 for GBA1 and FA programs - LEXINGTON, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it has decided to assess alternate payloads related to its gene therapy program for superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS).

Tilray Expands Medical Cannabis Portfolio in Germany — Neutral
TLRY GlobeNewsWire — February 11, 2025NEUMÜNSTER, Germany, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, is pleased to announce the expansion of its industry-leading medical cannabis extract portfolio in Germany. Tilray's new medical cannabis offerings in Germany includes the introduction of an additional product size for its top-selling medical cannabis extract, along with a new formulation aimed at addressing the diverse needs of patients and healthcare providers.

FINAL REMINDER ENPH DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Enphase Energy, Inc. Investors to Participate in the Class Action Lawsuit — Neutral
ENPH Accesswire — February 11, 2025NEW YORK CITY, NY / ACCESS Newswire / February 11, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Enphase Energy, Inc. ("Enphase" or "the Company") (NASDAQ:ENPH) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Enphase securities between April 25, 2023 and October 22, 2024, both dates inclusive (the "Class Period").

GlobalFoundries Reports Fourth Quarter 2024 and Fiscal Year 2024 Financial Results — Neutral
GFS GlobeNewsWire — February 11, 2025MALTA, N.Y., Feb. 11, 2025 (GLOBE NEWSWIRE) -- GlobalFoundries Inc. (GF) (Nasdaq: GFS) today announced preliminary financial results for the fourth quarter and fiscal year ended December 31, 2024.

Bill Ackman Just Bought Uber Stock. 3 Reasons I'm Staying Away. — Negative
UBER The Motley Fool — February 11, 2025Last week, the stock of Uber Technologies went on a wild ride, falling hard after Uber reported earnings on Feb. 5, only to rocket higher toward the end of the week.

I May Buy Into The Starlink IPO (When It Happens) But I'm Still Buying Cell Tower REITs — Positive
AMT CCI Seeking Alpha — February 11, 2025Starlink, a SpaceX subsidiary, aims to revolutionize global connectivity with 7,000 satellites and over 4 million subscribers, despite challenges like limited bandwidth and high costs. American Tower and Crown Castle are key players in communications infrastructure, with AMT showing strong growth and CCI facing potential dividend cuts. Cell towers and satellites complement each other, with towers providing high-capacity, low-latency communication and satellites extending coverage to remote areas.

CRBU INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Caribou Biosciences, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! — Neutral
CRBU Accesswire — February 11, 2025NEW YORK CITY, NY / ACCESS Newswire / February 11, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Caribou Biosciences, Inc. ("Caribou" or "the Company") (NASDAQ:CRBU) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Caribou securities between July 14, 2023 and July 16, 2024, both dates inclusive (the "Class Period").

NEM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Newmont Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! — Neutral
NEM Accesswire — February 11, 2025NEW YORK, NY / ACCESS Newswire / February 11, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Newmont Corporation ("Newmont" or "the Company") (NYSE:NEM) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Newmont securities between February 22, 2024 and October 23, 2024, both dates inclusive (the "Class Period").

RADCOM Announces Integration with ServiceNow to Automate Service and Complaint Resolution for Telecom Operators — Neutral
RDCM PRNewsWire — February 11, 2025Collaboration leverages AIOps to drive network efficiencies and enhance customer satisfaction with combined service management and service assurance solutions TEL AVIV, Israel , Feb. 11, 2025 /PRNewswire/ -- RADCOM Ltd. (Nasdaq: RDCM) announced today the integration of RADCOM RAN Analytics Solution, part of RADCOM ACE Service Assurance, with ServiceNow, leveraging AIOps (the use of Artificial Intelligence technology to automate Operations) to offer advanced automated complaint resolution.

Marriott International Reports Fourth Quarter and Full Year 2024 Results — Neutral
MAR PRNewsWire — February 11, 2025Fourth quarter 2024 RevPAR 1 increased 5.0 percent worldwide, with 4.1 percent growth in the U.S. & Canada and 7.2 percent growth in international markets Fourth quarter reported diluted EPS totaled $1.63 and adjusted diluted EPS totaled $2.45 Fourth quarter reported net income totaled $455 million and adjusted net income totaled $686 million Fourth quarter adjusted EBITDA totaled $1,286 million With record gross room additions of over 123,000 in 2024, net rooms grew 6.8 percent from year-end 2023 At the end of the year, Marriott's worldwide development pipeline totaled nearly 3,800 properties and over 577,000 rooms The company returned over …

ListenAI Licenses Ceva-Waves Wi-Fi 6 IP, Bringing Seamless Wireless Connectivity to its Edge AI Portfolio — Neutral
CEVA PRNewsWire — February 11, 2025ROCKVILLE, Md. , Feb. 11, 2025 /PRNewswire/ -- Ceva, Inc. (NASDAQ: CEVA), the leading licensor of silicon and software IP that enables Smart Edge devices to connect, sense and infer data more reliably and efficiently, today announced that ListenAI Technology (ListenAI), a pioneering leader in intelligent terminal system-on-chip (SoC) solutions, has licensed the Ceva-Waves Wi-Fi 6 IP to enhance its portfolio of Edge AI processors.

SolarBank Provides Update on 14.4 MW Projects in Skaneateles, New York — Neutral
SUUN PRNewsWire — February 11, 20252,100 Homes Expected to be Powered by these Community Solar Projects TORONTO , Feb. 11, 2025 /PRNewswire/ - SolarBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) ("SolarBank" or the "Company") is pleased to announce an update on the development of two projects located on industrial brownfield sites located in Skaneateles, New York which is in the Finger Lakes Retion of New York, in Onnodaga County. The Company intends to develop two ground-mount community solar projects across the this site with a capacity of 14.4 MW DC (the "Projects").

Moving iMage Technologies Second Quarter Fiscal 2025 Results Conference Call and Webcast — Neutral
MITQ Newsfile Corp — February 11, 2025Fountain Valley, California--(Newsfile Corp. - February 11, 2025) - Moving iMage Technologies (NYSE American: MITQ) will host a conference call discussing financial and operational results for its second quarter of 2025 ended December 31, 2024, on Thursday, February 13, 2025 at 11:00 a.m. Eastern Time.

MGPI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of MGP Ingredients, Inc. to Contact the Firm Today! — Neutral
MGPI Accesswire — February 11, 2025NEW YORK CITY, NY / ACCESS Newswire / February 11, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against MGP Ingredients, Inc. ("MGP Ingredients" or "the Company") (NASDAQ:MGPI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired MGP Ingredients securities between May 3, 2023 and October 30, 2024, both dates inclusive (the "Class Period").

ESSA Pharma Reports Financial Results for Fiscal First Quarter Ended December 31, 2024 — Neutral
EPIX PRNewsWire — February 11, 2025Company continues to explore and review strategic options focused on maximizing shareholder value SOUTH SAN FRANCISCO, California and VANCOUVER, Canada , Feb. 11, 2025 /PRNewswire/ - ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX), a pharmaceutical company that, prior to the discontinuation of its clinical trials and development programs, has been focused on developing novel therapies for the treatment of prostate cancer, today reported financial results for the fiscal first quarter ended December 31, 2024. "Following our decision to terminate the clinical development of masofaniten, we have been evaluating and reviewing strategic options with a focus on maximizing shareholder …

Shopify Merchant Success Powers Q4 Outperformance Across Both Top and Bottom-Line — Neutral
SHOP Newsfile Corp — February 11, 2025Q4 Revenue Growth Accelerates to 31% and Free Cash Flow Margin Expands to 22%; Full Year Revenue Up 26% and Free Cash Flow Margin Increases to 18% Internet, Everywhere--(Newsfile Corp. - February 11, 2025) - Shopify Inc. (NYSE, TSX: SHOP), a leading commerce technology company announced today financial results for the quarter and year ended December 31, 2024. "2024 was a stand-out year for Shopify.
